CUBE vs LUNG · P/E 25, rev $1.07B vs rev $83.8M
CubeSmart (CUBE) versus Pulmonx Corp (LUNG) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Pulmonx Corp (LUNG) is a medical devices company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported LUNG revenue for 2024-12-31 was $83.8M. Net income was -$56.4M. Revenue was up 22.0% from 2023-12-31 to 2024-12-31. LUNG currently screens at market cap $111.9M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. LUNG currently screens at market cap $111.9M.
Not investment advice. Open the CUBE and LUNG stock pages for the full models.
Not investment advice.